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The DNase of Epstein–Barr virus (EBV) is a 470-amino-acid protein which possesses both endonuclease and exonuclease
activities and accepts both double-stranded DNA and single-stranded DNA as substrates. It has been reported that this
protein may be found in the nucleus and/or cytoplasm of infected cells. In this study, using cell fractionation and
immunoblotting to determine the distribution of EBV DNase in Akata cells stimulated with anti-human immunoglobulin G
antibody (anti-IgG), the DNase was found to be located predominantly in the nucleus. To map the signals in DNase which
mediate its nuclear localization, we monitored the nuclear transport of fusion proteins consisting of various fragments of EBV
DNase linked to a cytoplasmic protein, b-galactosidase (b-Gal). The results demonstrated that two regions of the DNase with
nuclear localization signal (NLS) activity, designated NLS-A (amino acids 239–266) and NLS-B (amino acids 291–306), were
able independently to localize the b-Gal to the nuclei of HEp-2 and HeLa cells. Five basic residues (R or K) were found in each
NLS and distributed differently in primary structure. The basic domains and flanking residues of NLS-A and NLS-B are
250YKRPCKRSFIRFI262 and 294LKDVRKRKLGPGH306, respectively. Further examination of these sequences revealed that
NLS-A contains bulky aromatic amino acids (Y and F) which may diminish its capacity to act as a strong NLS and lacks the
typical proline and glycine helix-breakers. However, NLS-B contains typical proline and glycine helix-breakers and the
histidine residue at amino acid 306 is required for NLS activity. In addition, two hydrophobic regions within the DNase were
found to inhibit the function of NLS-A but not NLS-B, suggesting that these two domains are different types of NLSs and differ
in their sensitivity to hydrophobic regions in the context of protein structure. © 1998 Academic Press
INTRODUCTION
Epstein–Barr virus (EBV), a member of Herpesviridae,
is the etiological agent of infectious mononucleosis (IM)
(Henle et al., 1968) and is associated with several can-
cers including Burkitt’s lymphoma (BL) (Epstein et al.,
1964), nasopharyngeal carcinoma (NPC) (Henle et al.,
1970), oral hairy leukoplakia (OHL) (Greenspan et al.,
1985), T-cell lymphoma (Su et al., 1991), and Hodgkin
disease (Weiss et al., 1989). In vitro, EBV infection is
restricted to B-lymphocytes, which become latently in-
fected and immortalized. At least 11 EBV genes are
expressed in latent infection. Of these genes, 2 encode
small, nonpolyadenylated RNAs (EBER 1 and EBER 2), 6
encode nuclear proteins (EBNA 1, 2, 3A, 3B, 3C, and LP),
and 3 encode integral membrane proteins (LMP1, 2A,
and 2B). The latent state in infected B-cells can be
disrupted by treatment with agents such as 12-O-tetra-
decanoylphorbol-13-acetate (TPA), cross-linking of sur-
face immunoglobulin, or superinfection. After EBV acti-
vation, lytic proteins including immediate early antigens
(IE), early antigens (EA), virus capsid antigens (VCA), and
membrane antigens (MA) are expressed in sequence
and infectious virus can be produced. These viral pro-
teins are synthesized in the cytoplasm and then trans-
ported to their target sites.
In general, protein localization is integral to regulation
of function and the subcellular distribution of proteins is
regulated by various mechanisms, such as signal-de-
pendent localization, modification (e.g., phosphorylation),
and interaction with other proteins (Jans and Hubner,
1996). In EBV-infected cells, nuclear localizations of
EBNA-1 and EBNA-2 are mediated by NLS (Ambinder et
al., 1991; Cohen et al., 1991). Zta and EA-D proteins are
found to localize in the nucleus in activated EBV-harbor-
ing cell lines, cells transiently expressing individual gene
products, and NPC biopsies (Pearson et al., 1983; Cho et
al., 1985; Cox et al., 1990; Takagi et al., 1991; Cochet et al.,
1993). However, the Zta proteins may also be found in the
cytoplasm of the basal epithelial layer and in the nucleus
of the upper stratum spinosum in OHL biopsies, suggest-
ing that their localization is dependent on the differenti-
ation of epithelial cells (Becker et al., 1991). In activated
EBV-producing lymphoblastoid cells, Zta proteins are
shown with a diffuse intranuclear distribution early after
activation, but later are concentrated in globular regions
within the nucleus. EA-D proteins appear first in a fine
stipple pattern, then in a diffuse pattern, and later are
concentrated in globular regions similar to Zta proteins.
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The redistributions of both Zta and EA-D proteins were
proposed to be involved in the replication of lytic viral
DNA (Takagi et al., 1991). The transport mechanisms of
these two proteins are unknown.
In common with herpesviruses, EBV produces a spe-
cific deoxyribonuclease (DNase) activity detectable early
in the lytic cycle which has been shown to have both
endonuclease and exonuclease activities. DNase also
has a strong requirement for divalent cations and an
alkaline pH for optimal activity (Clough, 1979, 1980).
DNase activity was also found in superinfected Raji cells
and in chemically treated D98/HR-1 cells (Cheng et al.,
1980b). DNase activity could be neutralized by sera from
patients with NPC. Patients with NPC have higher levels
of antibody against EBV DNase than normal controls and
their antibody levels may be raised prior to the appear-
ance of clinical symptoms of NPC (Cheng et al., 1980a;
Chen et al., 1982, 1985a, b, 1989). DNase was shown to
localize to the nuclei in recombinant baculovirus-infected
cells and some OHL biopsies (Baylis et al., 1991a, b;
Chen et al., 1991). In some NPC biopsies, the expression
of EBV DNase was found in relatively large zones of
malignant cells with both nuclear and cytoplasmic dis-
tribution. But in other NPC biopsies, the DNase was
localized at the periphery of the nucleus or more abun-
dantly in the cytoplasm (Sbih-Lammali et al., 1996). The
nuclear targeting mechanism of EBV DNase is unknown.
In this study, we investigated the nuclear signaling se-
quences within the EBV DNase. The results revealed that
two nuclear localization signals (NLSs) (NLS-A and
NLS-B) within EBV DNase independently could localize
b-Gal to the nuclei of HEp-2 and HeLa cells. In addition,
we found that two hydrophobic regions within EBV
DNase inhibit the function of NLS-A but not NLS-B, sug-
gesting that there are different types of nuclear localiza-
tion signal in that protein.
RESULTS
The subcellular distribution of EBV DNase in
activated Akata cells
Akata cells could be activated synchronously and
expression of virus-specific early proteins, such as
EA-D and DNase, was detectable 6 h post-IgG treat-
ment (Daibata and Sairenji, 1993). Cell fractionation
and immunoblotting methods were used to determine
the distribution of EBV DNase in activated Akata cells.
At 6 h after activation, DNase could be detected in the
nuclear and cytoplasmic fractions. EA-D and the major
DNA binding protein (mDBP) were located in the nu-
cleus and could not be detected in the cytoplasm. At
12, 18, and 24 h after activation, DNase was predom-
inantly located in the nucleus. The amount of DNase in
the cytoplasmic fractions did not increase with time
postactivation (Fig. 1).
Identification of the regions for nuclear localization
in EBV DNase
Most nuclear proteins contain NLSs that facilitate their
transport into the nucleus through the nuclear mem-
brane. The NLSs can be classified into three categories:
prototype NLS, consisting of a short stretch of basic
amino acids, such as the sequence PKKKRKV in SV40
T-antigen (Kalderon et al., 1984); bipartite NLS, consisting
of two clusters of basic residues separated by 10–12
amino acids, such as that of Xenopus laevis nucleoplas-
min (Dingwall et al., 1989); and less well conserved
sequences with few basic residues, such as that of the
adenovirus E1a (KRPRP; Lyons et al., 1987) or influenza A
virus NP (SQGTKRSYEQM; Wang et al., 1997). Most of the
nuclear proteins with molecular masses of greater than
60 kDa must be actively transported into the nucleus,
while those of less than 40 kDa can pass the nuclear
membrane by diffusion (Nigg et al., 1991). To identify the
region(s) responsible for the nuclear translocation of EBV
DNase, various truncated DNase fragments were ligated
to pCMV-lacZ in-frame, in which a protein composed of
five residues (MGTPG) of PCR product and 8–1021 amino
acids of b-Gal was encoded under the control of a CMV
immediate-early gene promoter (Figs. 2A and 2B). The
expression of DNase–b-Gal constructs transfected into
HEp-2 or HeLa cells was monitored for the intracellular
location by enzymatic staining of b-Gal. The expression
of pCMV-lacZ was detected only in the cytoplasm (Fig.
2C), but fusion proteins of b-Gal and 31–377 residues of
DNase (placZ-31-377), which contain most of the basic
residues within DNase, were expressed in the nucleus
and cytoplasm (Fig. 2C). In contrast, a fusion protein of
b-Gal and residues 31–233 and 358–377 of EBV DNase
(placZ-31-377D224-357) gave only cytoplasmic staining
(Fig. 2C). When the region of residues 239–378 of DNase
was fused with b-Gal (placZ-239-378), the protein was
located to the nucleus and cytoplasm (Fig. 2C). To further
define the regions precisely responsible for nuclear lo-
calization of EBV DNase, the domain of residues 239–
378 was divided into three portions—residues 239–302,
FIG. 1. Subcellular localization of EBV DNase, major DNA binding
protein (mDBP), and EA-D by subcellular fractionation. Akata cells were
treated with anti-human IgG and harvested at the times indicated.
Cytoplasmic (C) or nuclear (N) extracts were prepared as described
under Materials and Methods. After subcellular fractionation, each
fraction was run on SDS–PAGE and electroblotted to Hybond C super-
membrane. The resulting blot was incubated with antibody against
DNase and then stripped and reprobed with antibodies against mDBP
and EA-D, respectively. The reactions were detected by ECL.
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305–378, and 291–378—and ligated to b-Gal in frame
(placZ-239-302, placZ-305-378, and placZ-291-378, re-
spectively). The expressed products of placZ-239-302
and placZ291-378 were detected in the nucleus (Fig. 2C),
but the protein encoded by placZ-305-378 was located to
the cytoplasm (Fig. 2C). These data indicate that there is
FIG. 2. (A) Schematic diagram of the construct of pCMV-lacZ. Three restriction enzyme sites, KpnI, SmaI, and BamHI, between sequences of the CMV
promoter and b-Gal, were used to insert the fragments of EBV DNase. (B) Relative position of peptide fragments in EBV DNase used to generate the b-Gal
fusion proteins. Numbering refers to the nucleic acid (1 to 1410 bp) and amino acid sequences (1 to 470 a.a.) of EBV DNase. The indicated restriction sites
were used to digest and remove the DNA fragment of DNase as described under Materials and Methods. Black rectangles represent the fragments of
DNase fused to b-Gal in each construct. The subcellular localizations of these fusion proteins are indicated on the right: C, cytoplasm; N, nucleus; C, N,
cytoplasm and nucleus. (C) Micrographs showing subcellular localization of DNase–b-Gal constructs, pCMV-lacZ, placZ-31-377, placZ-31-377D224-357,
placZ-239-378, placZ-239-302, placZ-305-378, and placZ-291-378, in transiently transfected HEp-2 cells via b-Gal staining.
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NLS activity within the residues 239–302 of DNase,
which is able to direct b-Gal from cytoplasm to nucleus.
Two nuclear localization signals in EBV DNase
An NLS is composed of a stretch of basic residues and
there are two stretches of basic residues within residues
239–302 of DNase: amino acids 251–260 (KRPCKRSFIR)
and amino acids 295–301 (KDVRKRK). The motif of amino
acids 295–301 (KDVRKRK) is similar to the type-I NLS
(SV40 T-antigen-like) and the other seems to resemble a
type-III NLS. To determine whether these two motifs
function as NLS, the domain comprising amino acids
239–302 of DNase was further dissected into small por-
tions and fused to b-Gal in-frame, to generate placZ-291-
302, placZ-239-291, and placZ-239-266. The expression
of placZ-291-302 in HEp-2 (Fig. 3) and HeLa cells (data
not shown) revealed a diffuse cytoplasmic pattern, along
with intense perinuclear staining, and both placZ-239-
FIG. 2—Continued
FIG. 3. Micrographs showing subcellular localization of DNase–b-Gal constructs, placZ-291-302, placZ-239-291, placZ-239-266, placZ-291-304,
placZ-291-305, and placZ-291-306, in transiently transfected HEp-2 cells via b-Gal staining. The amino acid sequences of residues 291–306 and
239–266 of EBV DNase are 291AWNLKDVRKRKLGPGH306 and 239FDPIYPSYTALYKRPCKRSFIRFINSIA266.
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291 and placZ-239-266 were shown to exhibit nuclear
staining (Fig. 3). These data indicated that residues 239–
266 of EBV DNase contained an NLS, designated NLS-A,
sufficient to direct b-Gal from the cytoplasm to the nu-
cleus. The finding that the protein encoded by placZ-291-
378 was located in the nucleus (Fig. 2C) but placZ-291-
302 was located in the cytoplasm implied that se-
quences downstream of residues 291–302 could be
essential for NLS function. To test this hypothesis, placZ-
291-304, placZ-291-305, and placZ-291-306 were con-
structed and transfected into HEp-2 and HeLa cells. The
expression of placZ-291-304 and placZ-291-305 was the
same as that of placZ-291-302, in the cytoplasm (Fig. 3).
However, the expression of placZ-291-306 was concen-
trated in the nucleus. These data indicated that residues
291–306 (291AWNLKDVRKRKLGPGH306) of EBV DNase
contain another NLS, designated NLS-B, which is suffi-
cient to direct b-Gal from the cytoplasm to the nucleus.
The histidine residue at amino acid 306 is required for
NLS-B function.
Two hydrophobic regions modulate the function of
NLS-A, but not NLS-B
To confirm the function of NLS-A and NLS-B, NLS-B
was deleted from placZ-239-378 to generate placZ-239-
378D292-304. Expression of placZ-239-378D292-304 in
HEp-2 (Fig. 4) and HeLa cells (data not shown) was
detected in the cytoplasm. This conflicted with the find-
ing that NLS-A is sufficient to direct b-Gal from the
cytoplasm to the nucleus. It has been reported that some
NLSs were sensitive to protein context (Roberts et al.,
1987) and the function of NLS-A may be affected by
residues 305–378 of EBV DNase. To clarify the discrep-
ancy and test the ability of residues 305–378 to inhibit the
function of NLS-A, placZ-239-346D292-304 and placZ-
239-324D292-304 were derived from placZ-239-378D292-
304 retaining the regions of amino acids 305–346 and
305–324, respectively. Expression of placZ-239-346D292-
304 in HEp-2 cells was detected in the cytoplasm (Fig. 4),
but the protein encoded by placZ-239-324D292-304 was
located in the nucleus (Fig. 4). Therefore, residues 305–
346 of DNase, designated the hydrophobic region 1
(HR1), can inhibit the function of NLS-A. Because the
protein expressed by placZ-291-378 containing NLS-B
and HR1 was located in the nucleus (Fig. 2C), HR1 did
not seem to inhibit NLS-B activity. To determine whether
the distance between NLS-A and HR1 influences the
inhibition of HR1 to the NLS-A, the placZ-239-266/304-
377 was constructed. The protein of placZ-239-266/304-
377 was found in the cytoplasm (Fig. 4). Since proteins
encoded by both placZ-239-378D292-304 and placZ-239-
266/304-377 were located in the cytoplasm, the spacer of
25 residues (291 to 265) between NLS-A and HR1 did not
prevent the inhibition of HR1.
Besides HR1, there is a large hydrophobic region at
the C-terminus of EBV DNase, designated HR2 (Fig. 5A).
To determine whether HR2 has the same effect as HR1,
residues 384–439 of EBV DNase were ligated to b-Gal or
inserted into placZ-239-266, placZ-291-302, and placZ-
291-306 to generate placZ-384-439, placZ-239-266/384-
439, placZ-291-302/384-439, and placZ-291-306/384-439,
respectively. The expression of placZ-384-439 in HEp-2
(Fig. 5B) and HeLa (data not shown) cells was located in
the cytoplasm concentrated in globular regions rather
than with a diffuse distribution. The expression of placZ-
239-266/384-439 and placZ-291-302/384-439 was ob-
served in the cytoplasm, but the protein encoded by
placZ-291-306/384-439 was detected in the nucleus (Fig.
5B). These data indicated that, in addition to HR1, HR2
also can inhibit the function of NLS-A but not NLS-B.
Effect of deletion of NLS-A or NLS-B on the
translocation of EBV DNase
To investigate the function of NLS-A and NLS-B in the
whole DNase protein, an immunofluorecence assay of
HEp2 cells transfected with a CMV promoter-driven full-
length or mutated DNase construct was performed. Al-
though the expression of full-length DNase was detected
in the nucleus, expressed proteins from constructs lack-
ing the NLS-A, NLS-B, and/or C-terminal hydrophobic
regions could be detected in either the nucleus or cyto-
plasm (Fig. 6A). For example, proteins encoded by
pCMV-ID7, which was deleted for residues 292–304 and
lost the NLS-B activity, exhibited cytoplasmic staining
(Fig. 6B, pCMV-ID7); however, the product of pCMV-ID8
lacking the NLS-A remained in the nucleus (Fig. 6B,
pCMV-ID8).
Deletion of the C-terminal 325–470 residues of pCMV-
FIG. 4. Micrographs showing subcellular localization of DNase–b-Gal
constructs, placZ-239-378D292-304, placZ-239-346D292-304, placZ-239-
324D292-304, and placZ-239-266/304-377, in transiently transfected HEp-2
cells via b-Gal staining.
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ID7 resulted in a predominant nuclear localization indis-
tinguishable from pCMV-CD324, which encoded resi-
dues 1–324 of DNase containing both NLS-A and NLS-B
(Fig. 6B, pCMV-CD324D292-304 and pCMV-CD324).
These data indicated that NLS-B but not NLS-A alone
was sufficient to direct nuclear localization of DNase in
HEp2 cells and the function of NLS-A was inhibited by
the C-terminal hydrophobic region in the whole DNase
protein as well as in fusion proteins.
DISCUSSION
In this study, we have determined the NLS activity of
several peptide fragments derived from the EBV DNase
protein using b-Gal fusion proteins expressed from the
CMV immediate-early promoter. Since Escherichia coli
b-Gal protein (; 128 kDa) is a cytosolic protein and the
insertion of a NLS can direct it to the nucleus (Knauf et
al., 1996; Chang et al., 1992), this system is useful in
mapping the NLS regions of nuclear proteins. In the
present report, two regions (NLS-A and NLS-B) from EBV
DNase were identified with NLS activity for nuclear
translocation of b-Gal fusion proteins in HEp-2 and HeLa
cells. These sequences, NLS-A and NLS-B, each con-
tained five basic residues (R or K); however, they were
distributed differently in the primary structure. NLS-A,
with basic amino acids 251KRPCKRSFIR260, belonged to
type III NLS, and NLS-B contained the SV40 T-antigen-
like NLS sequence 295KDVRKRKLGPGH306 (basic resi-
dues in bold). Inspection of the residues flanking the
basic domains of NLS-A and NLS-B revealed that NLS-A
contained bulky aromatic amino acids (Y and F) pro-
posed to diminish its capacity to act as a strong NLS
(Boulikas, 1996), and the typical proline and glycine helix-
breakers were lacking. Furthermore, the function of
NLS-A was inhibited by two hydrophobic regions within
the DNase. In contrast, NLS-B contained the typical pro-
FIG. 5. (A) The position of predicted hydrophobic regions of EBV DNase. Hydrophobicity of EBV DNase was measured using the PEPPLOT file of
the GCG package (version 7). HR1 and HR2 are indicated by closed boxes. (B) Micrographs showing subcellular localization of DNase–b-Gal
constructs, placZ-384-439, placZ-239-266/384-439, placZ-291-302/384-439, and placZ-291-306/384-439, in transiently transfected HEp-2 cells via b-Gal
staining.
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line and glycine helix-breakers and required His306 for
its NLS function. It was reported that a histidine residue
flanked by proline or glycine was proposed to act in the
nuclear import of PKC (Boulikas, 1996). In NLS-B, the
presence of basic residues alone did not direct fusion
proteins to the nucleus, but led to intense perinuclear
staining (Fig. 3). Nuclear protein import is accomplished
by two sequential events: docking with karyopherin a
and translocation through the nuclear membrane (Jans
and Hubner, 1996). In the absence of histidine (residue
306), the NLS-B fusion protein may still have bound to
karyopherin a at the nucleus membrane, but did not pass
through the nuclear pore complex. The presence of
His306 resulted in the translocation of fusion proteins
through the nuclear complex (Fig. 3, placZ-291-306). In
addition, two hydrophobic regions within DNase did not
inhibit the function of NLS-B. These data suggest that the
two NLSs of EBV DNase were of different types and were
different in sensitivity to hydrophobic regions in the pro-
tein context.
The presence of multiple NLSs within a single mole-
cule has been observed in many other proteins (Knauf et
al., 1996; Mears et al., 1995; Boulikas, 1997). Interestingly,
DNA repair proteins usually possess multiple NLSs,
such as XPC protein, which contains eight strong and
seven weak NLSs (Boulikas, 1997). It is not clear why a
single protein requires multiple NLSs, which may differ in
properties such as transport efficiency. For instance, the
FIG. 6. (A) Schematic representation of mutated DNase. The full-length, 470-amino-acid EBV DNase is represented by a long bar and the relative
positions of NLS-A and NLS-B are shown under the bar. Numbering refers to the amino acid residues of EBV DNase. Translated regions of proteins
are indicated by closed boxes, and the deleted regions are indicated by open boxes. Subcellular localizations of proteins are indicated on the right:
C, cytoplasm, and N, nucleus. (B) Immunofluorescence analysis of subcellular localization of full-length and mutant EBV DNase proteins in transfected
HEp-2 cells. HEp-2 cells transfected with pCMV-BG9, pCMV-ID7, pCMV-ID8, pCMV-CD324, or pCMV-CD324D292-304 were stained by using
immunofluorescence assay as described under Materials and Methods.
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ICP27 of herpes simplex virus (HSV) contains a strong
NLS, mapping to residues 110 to 137, and one or more
weak signals, mapping to residues 140–512 (Mears et al.,
1995). A possible explanation for multiple NLSs in a
single protein is that these can cooperate to enhance
nuclear accumulation (Roberts et al., 1987). Although
individual NLSs can direct the heteroproteins to the nu-
cleus, multiple NLSs can function more efficiently (Knauf
et al., 1996; Roberts et al., 1987). Alternatively, NLSs may
function in different cell types with different efficiencies.
It has been reported that karyopherins hSRP1 and
hSRP1a (NLS binding proteins) are differentially ex-
pressed in various leukocyte cells and bind with varied
specificities to different NLSs in a sequence-specific
manner (Nadler et al., 1997). EBV can infect both B-cells
and epithelial cells in vivo. Whether NLS-A and NLS-B of
EBV DNase function differently in B-cells and epithelial
cells needs further study.
Our experiments demonstrated that two hydrophobic
regions (amino acids 305–346, HR1, and amino acids
384–439, HR2) within DNase can inhibit the function of
NLS-A but not NLS-B. Possession of NLSs, while neces-
sary, is not sufficient to ensure nuclear import. The NLS
activity may be masked by another domain(s) or by other
proteins and may be modulated by phosphorylation (Jans
and Hubner, 1996). Furthermore, nuclear export signals
(NESs), which induce the rapid and active nuclear export
of macromolecules, appear to override the activity of
NLSs. It has been reported that the function of NLS is
affected by its intramolecular position. For example, the
NLS of SV40 large T can function at various positions
within pyruvate kinase but in some locations its activity is
masked (Roberts et al., 1987). Because the NLS interacts
with karyopherin a to exert its function, the NLS must be
folded into a specific structure and exposed on the pro-
tein surface. One possible explanation for the effect of
HRs of EBV DNase to NLSs is that the two HRs may
influence the exposure of NLS-A. However, the functional
structure of NLS-B was not disrupted by HRs. Alterna-
tively, HRs within EBV DNase may possess NESs activity.
Some hydrophobic motifs were identified as NESs (Fi-
scher et al., 1996). The NES of a heat-stable inhibitor of
cAMP-dependent protein kinase is a slightly weaker sig-
nal than the SV40 NLS (Wen et al., 1995), but FMRP
(fragile X mental retardation protein) contains both NLSs
and NESs and the NES activity overrides that of NLS
(Eberhart et al., 1996). Thus, a protein containing both
NESs and NLSs can transport in either direction depend-
ing on the strength of NLS or NES. Other regulations,
such as phosphorylation and interaction with other pro-
teins, also affect the final destination. If HRs of EBV
DNase contain NESs, the NES activity is stronger than
NLS-A but weaker than NLS-B. Therefore, NESs can
override NLS-A but not NLS-B. EBV DNase was shown to
localize in the nuclei of Akata cells (Fig. 1), recombinant
baculovirus-infected cells, and some OHL biopsies (Bay-
lis et al., 1991a, b); however, in NPC biopsies, the expres-
sion of EBV DNase was observed in relatively large
zones of malignant cells with both nuclear and cytoplas-
mic distribution or at the periphery of the nucleus or
more abundantly in the cytoplasm (Sbih-Lammali et al.,
1996). The observation of varying subcellular location of
EBV DNase implies that multiple factors regulate the
localization of EBV DNase. In addition to NLSs and HRs,
it remains unknown whether the interaction of EBV
DNase and other proteins including EBV EA-D, DNA
polymerase, and mDBP (Daibata and Sairenji, 1993; Lin
et al., 1995) also influences the localization of EBV
DNase.
Little is known about the function of the DNase in EBV
replication. Certain evidence suggested that EBV DNase
may be involved in the reutilization of host cell DNA,
providing the virus with deoxyribonucleotides by degra-
dation of cellular DNA (Feighny et al., 1981). EBV DNase
was induced in parallel to EBV DNA polymerase (Cheng
et al., 1980b) and interacted with viral DNA replication
components (Daibata and Sairenji, 1993; Lin et al., 1995).
Because of the similarities among herpesvirus DNases,
this group of enzymes may play a similar role in the viral
life cycle. In the case of HSV, DNase was required for
efficient egress of capsids from the nucleus (Shao et al.,
1993) and for processing nonlinear or branched viral
DNA intermediates (Martinez et al., 1996). A 60-kDa ami-
no-terminal truncated form of DNase, derived from an
alternate open reading frame in HSV1, represents a cap-
sid-associated nuclease (Bronstein et al., 1997). There-
fore, the herpesvirus DNases may have multiple roles in
the process of lytic cycle. The DNase may be regulated
by the distribution of the protein for each role to be
played precisely; otherwise DNase probably causes
damage to host and viral DNA.
MATERIALS AND METHODS
Cells
Akata cells, a Burkitt’s lymphoma cell line (kindly pro-
vided by Dr. Takada), were maintained in RPMI 1640
supplemented with 10% fetal calf serum (Hyclone).
HEp-2, a human laryngeal malignant epithelial cell line,
and HeLa, a human epithelial-like cell line derived from
a cervical carcinoma, were cultured in Dulbecco’s mod-
ified Eagle’s medium (DMEM; Gibco) supplemented with
10% fetal calf serum.
Subcellular fractionation
Akata cells were washed twice with ice-cold PBS and
once in hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM
MgCl2; 10 mM KCl, 0.5 mM DTT, 0.5 mM PMSF). Cells
were kept in 0.4 ml of hypotonic buffer for 10 min on ice
and then homogenized with 20 strokes in a tight-fitting
glass Dounce homogenizer. The lysate was examined by
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light microscopy to ensure that most of the cells were
broken. The homogenate was centrifuged at 1000 g for 2
min. The supernatant fluids were collected and centri-
fuged at 15,000 g for a further 30 min at 4°C. The
supernatant fluids after high-speed centrifugation consti-
tuted the cytosolic extracts. The nuclear pellets from the
low-speed centrifugation were washed once with 1 ml of
hypotonic buffer and resuspended in 0.4 ml of nuclear
extraction buffer (20 mM HEPES, pH 7.9, 25% glycerol,
0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.6 mM DTT,
0.5 mM PMSF) and subsequently allowed to rotate at
4°C for 1 h. After centrifugation at 15,000 g for 30 min at
4°C, the supernatant fluids were collected as nuclear
extracts.
ECL Western blot analysis
The cytoplasmic and nuclear extracts were separated
by 10% sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis (SDS–PAGE) and transferred to Hybond C
supermembrane (Amersham). The blot was incubated
with blocking buffer (10 mM Tris–HCl, pH 8.0, 0.9% NaCl,
and 4% skim milk) for 1 h and reacted with anti-DNase
monoclonal antibody 311H (Tsai et al., 1997), EA-D (Tsai
et al., 1991), or polyclonal mouse anti-mDBP antibody
(Lin et al., 1995) for 1 h at room temperature. After
washing three times with washing buffer (10 mM Tris–
HCl, pH 7.4, 0.9% NaCl, 0.2% Tween 20), the blot was
incubated with horseradish peroxidase-labeled goat an-
ti-mouse IgG (Amersham) diluted 1:2500 with blocking
buffer for 1 h at room temperature. After incubation, the
blot was washed three times in washing buffer and once
with water and then developed with freshly prepared
substrate according to the manufacturer’s instructions
(ECL Western blotting, Amersham). The luminescence
was detected by a short exposure to X-ray film.
DNase and DNase–b-galactosidase fusion constructs
pGEM-BG9, a cDNA of the P3HR1 EBV DNase in a
vector of pGEM3Z (Promega) (Chen et al., 1990), was
subcloned to the eukaryotic expression vector pRc/CMV
(Invitrogen) to make pCMV-BG9. This was done by iso-
lating a 1.7-kb EcoRI–EcoRI fragment (filled in with Kle-
now enzyme) containing the DNase gene from pGEM-
BG9 and inserting it into the HindIII (filled in with Klenow
enzyme) site of pRc/CMV. pCMV-lacZ was constructed in
order to engineer DNase–b-galactosidase (b-Gal) fusion
genes. This was accomplished in several cloning steps.
First, a 3.7-kb BamHI fragment containing the prokaryotic
b-Gal coding region (codons 8–1021) was isolated from
plasmid pMC1871 (Pharmacia LKB) and cloned into the
BamHI/BglII sites of pOPRSVICAT (Stratagene). The
BamHI site at the 39 end was destroyed by ligation to the
BglII site. Then, the resulting plasmid was digested with
BamHI and NotI, and the BamHI–NotI fragment encoding
b-Gal isolated. Next, another DNA fragment containing
enhancer–promoter sequences from the immediate-
early gene of the human cytomegalovirus (CMV), the
functional 59 untranslated region of the EBV DNase, the
initiator codon (ATG), and three restriction enzyme sites
(KpnI, SmaI, and BamHI) was amplified by polymerase
chain reaction (PCR) with two primers containing SacII
(in the upstream primer), KpnI, SmaI, and BamHI (in the
downstream primer) recognition sites (underlined) (59TC-
CCCGCGGCTTCGCGATGTACG 39 and 59CGGGATCCCC-
GGGGGTACCCATCTGGACCAAAGAAG 39) and pCMV-
BG9 as the template. The PCR conditions were 1 cycle of
94°C for 3 min followed by 30 cycles of 94°C for 1 min,
55°C for 1 min, and 72°C for 1 min. The PCR product
(digested with SacII and BamHI) and BamHI–NotI frag-
ment (containing the b-Gal gene) were inserted between
the SacII and NotI sites of pOPRSVICAT to make pCMV-
lacZ (Fig. 2A), in which the b-Gal gene is under the
control of the CMV promoter and three restriction sites
(KpnI, SmaI, and BamHI) can be used for inserting the
DNA fragment encoding EBV DNase.
A StuI–SmaI fragment of pDNase5 (Chen et al., 1993),
containing residues 31–377 of EBV DNase, was intro-
duced into the BamHI site of pCMV-lacZ to generate
placZ-31-377. A KpnI–HindIII fragment of ID5, a mutant of
pDNase5 with an internal deletion of residues 347–357
(Liu et al., 1998), was substituted for the KpnI–HindIII
fragment of ID4, another mutant of pDNase5 with an
internal deletion of residues 224–238 (Liu et al., 1998), to
make the plasmid ID4-5, which had a deletion of codons
224–357 of the EBV DNase. Then a StuI–SmaI fragment
of ID4-5 containing the region encoding residues 31–377
(with deletion of codons 224–357) was introduced into
the BamHI site of pCMV-lacZ to generate placZ-31-
377D224-357. A KpnI–SmaI fragment of ID4, containing
residues 239–377, was inserted between the KpnI and
SmaI sites of pCMV-lacZ to make placZ-239-378. Con-
structs of placZ-239-302, placZ-305-378, placZ-291-378,
placZ-239-291, placZ-239-266, and placZ-239-378D292-
304 were derived from placZ-239-378 by digestion with
ApaI/BamHI, KpnI/ApaI, KpnI/StuI, StuI/XmaI, AluI/XmaI,
and StuI/ApaI, respectively, to remove the DNase-encod-
ing fragment and recircularization after filling in with
Klenow enzyme, to generate in-frame fusions of DNase
and b-Gal. The placZ-239-302 was cleaved with KpnI and
StuI to remove the DNA fragment encoding residues
239–290 of DNase, filled in with Klenow enzyme, and
recircularized to generate placZ-291-302. A PCR product
was amplified using placZ-291-378 as the template and
two primers: 59 TCCCCGCGGCTTCGCGATGTACG 39 with
a SacII restriction site (underlined) and 59 CAAAGGTAC-
CATGCCCGGGGCCCAG 39 (annealing to nt 904 to 918 of
EBV DNase sequence) with KpnI and SmaI restriction
sites (underlined). The PCR product was digested with
SacII and KpnI and inserted between the SacII and KpnI
sites of pCMV-lacZ to generate placZ-291-306. The
placZ-291-306 was digested with SmaI and BamHI/SmaI,
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filled in with Klenow enzyme, and recircularized to gen-
erate placZ-291-305 and placZ-291-304, respectively. A
PCR product, which was amplified using placZ-239-
378D292-304 as the template and IDP4s and IDP5a as
the primers (Liu et al., 1998), was inserted into the KpnI
site of pCMV-lacZ to generate placZ-239-346D292-304.
The placZ-239-378D292-304 was cleaved with SnaBI and
SmaI to remove the DNA fragment containing codons
325–378 of DNase and recircularized to generate placZ-
239-324D292-304. placZ-239-266/304-377 was generated
by inserting a filled-in ApaI–SmaI fragment encoding
residues 305–377 of DNase into the BamHI site (filled in
with Klenow enzyme) of placZ-239-266. A SmaI–SacII
fragment of pDNase5, encoding residues 384–439 of
DNase, was introduced into the BamHI sites (filled in
with Klenow enzyme) of pCMV-lacZ, placZ-239-266, and
placZ-291-302 to generate placZ-384-439, placZ-239-266/
384-439, and placZ-291-302/384-439, respectively. placZ-
291-306/384-439 was generated by insertion of the Sa-
cII–KpnI fragment from placZ-291-306 into the SacII/KpnI
sites of placZ-384-439. All constructs of DNase–b-Gal
and the restriction enzyme sites of EBV DNase used in
the cloning process were summarized in Fig. 2B.
Two constructs, pCMV-ID7 and pCMV-ID8, were de-
rived from pDNase5 containing EBV DNase in pET-3a
(Chen et al., 1993) by mutagenesis and subcloned to the
eukaryotic vector pRc/CMV. A StuI fragment of pDNase5
(nt 86–869) was introduced into the StuI and ApaI sites of
pDNase5 (digested with ApaI, then filled in with Klenow
enzyme, and finally digested with StuI) to generate ID7
(internal deletion 7) with the deletion of residues 292–
304 of DNase. In order to subclone DNase mutants in
pET3a into pRc/CMV, the pRc/CMV was modified to cre-
ate NdeI and ClaI sites for inserting the NdeI–ClaI frag-
ment of DNase mutants in the vector pET3a. This was
accomplished in several cloning steps. First, a DNA
fragment containing the functional 59 untranslated region
of EBV DNase and restriction sites of NdeI and ClaI was
amplified by PCR with two primers of 59TAGGGCGAAT-
TGGAGCTAGG39 and 59GCATCGATACGTCGGCCATATG-
GACC39 (ClaI and NdeI sites are underlined) and pOP-
RSVI-BG9 as the template. pOP-RSVI-BG9 was gener-
ated by isolating a 1.7-kb EcoRI–EcoRI fragment (filled in
with Klenow enzyme) containing the DNase gene from
pGEM-BG9 and inserting it into the NotI site of pOPRS-
VICAT (filled in with Klenow enzyme). Then, the PCR
product was inserted to the BxtXI and NotI sites of
pOPRSVICAT, and the resulting plasmid was cleaved by
HindIII and NheI to isolate a DNA fragment, which con-
tained the functional 59 untranslated region of EBV
DNase and restriction sites of NdeI and ClaI. This DNA
fragment was cloned into the HindIII and XbaI sites of
pRc/CMV, in which the original NdeI site of pRc/CMV
was destroyed by digestion with NdeI, filled in, and then
self-ligated, to generate the vector pRc/CMVXN. pCMV-
ID7 was generated by inserting the NdeI–ClaI fragment
of pID7 to the NdeI and ClaI sites of pRc/CMVXN. ID8
was constructed using recombinant PCR and the outside
primers IDP1L and IDP5R as described previously (Liu et
al., 1998). The sequences of inside primers, IDP8a and
IDP8s, are 59TAAAGGTACCGTAAAGCGCAGTGTAGGA39
and 59TTACGGTACCTTTATCAATTCTATAGCT39, contain-
ing the KpnI site (underlined). The NdeI–ClaI fragment of
ID8 with the deletion of residues 251–260 of DNase was
subcloned to the NdeI and ClaI sites of pRc/CMVXN to
generate pCMV-ID8. SnaBI fragments of pCMV-BG9 and
pCMV-ID7 (one SnaBI in the pRc/CMV and the other in nt
970 of EBV DNase) were isolated and inserted to the
SnaBI and XbaI sites of pCMV-BG9 (treated with XbaI,
Klenow enzyme, and SnaBI in sequence) to generate
pCMV-CD324 and pCMV-CD324D292-304, respectively.
The pCMV-CD324 encoded a truncated DNase with C-
terminal deletion of amino acid residues 325–470 and
was tagged with six residues (LEGPIL) from the vector of
pRc/CMV.
Transfections and b-galactosidase staining
Cells were transfected with 8 mg of CsCl density gra-
dient-purified plasmid DNA by the calcium phosphate
precipitation method. Briefly, HEp-2 or HeLa cells were
seeded at 1 3 105 cells per well in six-well dishes and
incubated overnight. Then the medium was changed and
500 ml of calcium phosphate precipitation solution (8 mg
of DNA, 125 mM CaCl2, 140 mM NaCl, 750 mM Na2HPO4,
25 mM HEPES, pH 7.0) was added to the dishes. The
precipitate was removed at 8 h of incubation, and the
cells were further incubated for 24 h. The subcellular
distribution of b-Gal and its fusion proteins was analyzed
by b-Gal enzymatic staining (Sanes et al., 1986). Briefly,
the transfected cells were washed with PBS and then
fixed with 2% (v/v) formaldehyde and 0.2% glutaraldehyde
for 5 min at room temperature. After fixation, the cells
were washed with PBS and incubated with developer (1
mg/ml X-Gal, 5 mM potassium ferricyanide, 5 mM potas-
sium ferrocyanide, 2 mM MgCl2). The stained cells were
observed with a Zeiss Axiophot microscope.
Immunofluorescence assay
Glass coverslips with transfected HEp-2 cells were
washed with PBS, fixed 1:1 with acetone and methanol at
220°C for 30 min, and subjected to indirect immunoflu-
orescence as described previously (Tsai et al., 1997). The
polyclonal mouse antiserum raised against EBV DNase
(Tsai et al., 1997) was diluted 1:100 in PBS as the primary
antibody. The cells were incubated with the primary
antibody in a moist chamber at 37°C for 30 min, and then
washed three times with PBS. The secondary antibody
was fluorescein isothiocyanate-conjugated goat anti-
mouse IgG (H 1 L) (Jackson, code: 115-095-003), diluted
1:100 in PBS. After incubation with secondary antibody at
37°C for 30 min, the cells were washed three times with
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PBS and visualized with a Zeiss Axioskop fluorescence
microscope.
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